Satoshi Kamidani

Also affiliated with Children's Healthcare of Atlanta

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant”.

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100679

N/A

5.1DataRank · unranked

167 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul Paul Chourdhury +64 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae148

N/A

0.707DataRank · unranked

11 citations

Christina A. Rostad, L. Nolan, Etza Peters, Jennifer Kleinhenz, Jacob D. Sherman +13 more

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases(2024)10.1093/cid/ciae173

N/A

0.384DataRank · unranked

11 citations

Robert L. Atmar, Emmanuel B. Walter, Sharon E. Frey, Jeffery L. Meier, Amy C Sherman +23 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose

npj Vaccines(2024)10.1038/s41541-024-01042-4

N/A

0.223DataRank · unranked

3 citations

İnci Yıldırım, Carol Kao, Jumi Yi, Satoshi Kamidani, Etza Peters +22 more

385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.455

N/A

0.104DataRank · unranked

1 citations

Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Sungeen Hill, Emily Wasserman +19 more

Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study

Vaccine(2023)10.1016/j.vaccine.2023.11.053

N/A

0DataRank · unranked

3 citations

Tomohiro Katsuta, Yurika Kawazoe, Masaki Takahashi, Fumiko Murata, Megumi Maeda +3 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023

UNC Libraries(2023)10.17615/m3qq-c893

N/A

0DataRank · unranked

2 citations

Samina S. Bhumbra, Charlotte V. Hobbs, Margaret M. Newhams, Elizabeth H. Mack, Regina M. Simeone +30 more

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

medRxiv(2023)10.1101/2023.06.06.23290973

N/A

0DataRank · unranked

0 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +31 more

430. Clinical Features and Outcomes of COVID-19 Hospitalized Adults by Variant

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.500

N/A

0DataRank · unranked

0 citations

Ashley Tippett, Ludy Registre Carmola, Laila Hussaini, Luis W Salazar, Olivia Reese +18 more

2621. Social Risk Factors for RSV-related Hospitalizations in Adults ≥ 50 years of age

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.2234

N/A

0DataRank · unranked

0 citations

Ashley Tippett, Laila Hussaini, Luis W Salazar, Olivia Reese, Caroline Ciric +14 more

Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions

Pathogens(2024)10.3390/pathogens13030200

N/A

0DataRank · unranked

25 citations

Lisa M. Cranmer, Satoshi Kamidani, Elizabeth Quincer

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7315a2

N/A

0DataRank · unranked

15 citations

Margaret M. Newhams, Regina M. Simeone, Amanda B. Payne, Michael Wu, Amber O. Orzel-Lockwood +94 more

Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study

Vaccines(2024)10.3390/vaccines12060657

N/A

0DataRank · unranked

4 citations

Ashley Tippett, Elizabeth Grace Taylor, Olivia Reese, Luis Rafael Moscote‐Salazar, Khalel De Castro +16 more

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023

UNC Libraries(2024)10.17615/v8x4-yz98

N/A

0DataRank · unranked

0 citations

Mia Maamari, Jemima M. Calixte, Stephanie P. Schwartz, Natalie Z. Cvijanovich, Melissa S. Stockwell +45 more

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants — 24 States, December 2024–April 2025

MMWR Morbidity and Mortality Weekly Report(2025)10.15585/mmwr.mm7437a1

N/A

0DataRank · unranked

5 citations

Regina M. Simeone, Margaret M. Newhams, Amanda B. Payne, Natasha Halasa, Amber O. Orzel-Lockwood +74 more

Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1425

N/A

0DataRank · unranked

92 citations

James D. Campbell, C. Buddy Creech, Robert W. Frenck, Satoshi Kamidani, Flor M. Muñoz +3 more

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial

Vaccine(2025)10.1016/j.vaccine.2025.127718

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Bo Zhang, Nadine Rouphael, Angela R Branche, Thomas Martin +13 more

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science(2021)10.1126/science.abj4176

N/A

0DataRank · unranked

602 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +82 more

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7102e1

N/A

0DataRank · unranked

247 citations

Margaret M. Newhams, Samantha M. Olson, Natasha B. Halasa, Ashley M. Price, Julie A. Boom +92 more

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7107e3

N/A

0DataRank · unranked

220 citations

Samantha M. Olson, Mary Allen Staat, Margaret M. Newhams, Ashley M. Price, Julie A. Boom +95 more

Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months

Academic Pediatrics(2022)10.1016/j.acap.2022.08.006

N/A

0DataRank · unranked

24 citations

Liza M. Reifler, Jason M. Glanz, Simon J. Hambidge, Darios Getahun, Stephanie A. Irving +8 more

Multiple MIS-C Readmissions and Giant Coronary Aneurysm After COVID-19 Illness and Vaccination: A Case Report

The Pediatric Infectious Disease Journal(2022)10.1097/inf.0000000000003801

N/A

0DataRank · unranked

10 citations

E. Gloria Anyalechi, Elizabeth P. Schlaudecker, Rachel McKay, Satoshi Kamidani, Cynthia K. Manos +2 more

Addressing the global burden of paediatric critical COVID-19 and mortality

The Lancet Regional Health - Americas(2022)10.1016/j.lana.2022.100301

N/A

0DataRank · unranked

1 citations

Christina A. Rostad, Evan J. Anderson, Satoshi Kamidani

Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7239a3

N/A

0DataRank · unranked

33 citations

Laura D. Zambrano, Natasha Halasa, Katherine E. Fleming-Dutra, Margaret M. Newhams, Michael Wu +80 more

Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad051

N/A

0DataRank · unranked

9 citations

Allan W. Taylor, Lara J. Akinbami, Andrea Thames-Allen, Anna R Yousaf, Angela P. Campbell +17 more

Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network

The Pediatric Infectious Disease Journal(2023)10.1097/inf.0000000000004225

N/A

0DataRank · unranked

5 citations

Margaret M. Newhams, Regina M. Simeone, Katherine E. Fleming‐Dutra, Natasha Halasa, Michael Wu +34 more